Scientific Online Resource System

Varna Medical Forum

The influence of miRNAs on the regulation of the immune system in inflammatory bowel disease

Antonia Atanassova


This review article presents the role of expression of various micro-RNAs in maintaining intestinal epithelial barrier function, maturation, and differentiation of immune cells that build innate and acquired immunity.


inflammatory bowel disease, microRNAs, immune system

Full Text


Атанасова А. Клинична оценка на пациентите с язвен колит- съвременен подход. Дисертация. МУ-Варна, 2014 г.

Agudo J, Ruzo A,Tung N,Salmon H,Leboeuf M,Hashimoto D,Becker C,Garrett-Sinha LA,Baccarini A,Merad M.The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nat Immunol.2014;15:54-62.

Akobeng AK.Crohn’s disease: current treatment options. Arch Dis Child.2008;93:787-792.

Anderson JM,Van Itallie CM.Physiology and function of the tight junction. Cold Spring Harb Perspect Biol.2009;1:a002584.

Ando, Y., Yang, G.‐X., Kenny, T. P., Kawata, K., Zhang, W., Huang, W., … Gershwin, M. E. (2013). Overexpression of microRNA‐21 is associated with elevated pro‐inflammatory cytokines in dominant‐negative TGF‐ β receptor type II mouse. Journal of Autoimmunity, 41, 111–119

Ashton J.J., Mossotto E., Ennis S. , Beattie M.R. Personalising medicine in inflammatory bowel disease—current and future perspectives. Transl Pediatr 2019;8(1):56-69.

Banerjee A, Schambach F, DeJong CS, Hammond SM, Reiner SL. Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol 2010; 40: 225-231 [PMID: 19877012 DOI: 10.1002/eji.200939381]

Berezin А.Е. and Eugen I Poplyonkin. Diagnostic and therapeutic value of micro-RNAs in inflammatory bowel disease. (2020) Biomedical Research and Therapy, 7(2):3622-3632.

Bhattacharyya, S., Balakathiresan, N. S., Dalgard, C., Gutti, U., Armistead, D., Jozwik, C., Biswas, R. (2011). Elevated miR‐155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin‐8. Journal of Biological Chemistry, 286(13), 11604–11615.

Boros E. and Nagy I.The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Cells 2019, 8, 1461; doi:10.3390/cells8111461

Brain O,Owens BM,Pichulik T,Allan P,Khatamzas E,Leslie A,Steevels T,Sharma S,Mayer A,Catuneanu AM.The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity.2013;39:521-536

Ceppi M,Pereira PM,Dunand-Sauthier I,Barras E,Reith W,Santos MA,Pierre P.MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA.2009;106:2735-2740

Cerwenka, A., & Lanier, L. L. (2016). Natural killer cell memory in infection, inflammation and cancer. Nature Reviews Immunology, 16(2), 112–123

Chen C-Z, Schaffert S, Fragoso R, et al. Regulation of immune responses and tolerance: the microRNA perspective. Immunol Rev 2013;253:112–28.

Chen CZ,Li L,Lodish HF,Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science.2004;303:83-86

Chen Y,Wang C,Liu Y,Tang L,Zheng M,Xu C,Song J,Meng X.miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn’s disease. Biochem Biophys Res Commun.2013;438:133-139.

Chuang AY,Chuang JC,Zhai Z,Wu F,Kwon JH.NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells. Inflamm Bowel Dis.2014;20:126-135.

Cichon C, Sabharwal H,Rüter C,Schmidt MA.MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers.2014;2:e944446

Cuthbert AP,Fisher SA,Mirza MM,King K,Hampe J,Croucher PJ,Mascheretti S,Sanderson J,Forbes A,Mansfield J.The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology.2002;122:867-874.

De Iudicibus S, Lucafò M. , Vitulo N. , Martelossi S. , Zimbello R. , De Pascale F. , et al. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients. Int. J. Mol. Sci. 2018, 19, 1399; doi:10.3390/ijms19051399

De Souza, H. S. P., & Fiocchi, C. (2016). Immunopathogenesis of IBD:Current state of the art.Nature Reviews Gastroenterology andHepatology,13(1), 13–27

Dunne A,O’Neill LA.Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett.2005;579:3330-3335

Elia,P.P.,Tolentino,Y.F.M.,Bernardazzi,C.,&deSouza,H.S.P.(2015). The role of innate immunity receptors in the pathogenesisof inflammatory bowel disease.Mediators of Inflammation, 2015,1–10

Escobar, T. M., Kanellopoulou, C., Kugler, D. G., Kilaru, G., Nguyen, C. K., Nagarajan, V., Muljo, S. A. (2014). MiR‐155 activates cytokine gene expression in Th17 cells by regulating the DNA‐binding protein Jarid2 to relieve polycomb‐mediated repression. Immunity, 40(6), 865–879

Fan, H.‐B., Liu, Y.‐J., Wang, L., Du, T.‐T., Dong, M., Gao, L.,Zhou, Y. (2014). MiR‐142‐3p acts as an essential modulator of neutrophil development in zebrafish. Blood, 124(8), 1320–1330

Geremia, A., Biancheri, P., Allan, P., Corazza, G. R., & Di Sabatino, A.(2014). Innate and adaptive immunity in inflammatory bowel disease.Autoimmunity Reviews,13(1), 3–10.

Ghisi, M., Corradin, A., Basso, K., Frasson, C., Serafin, V., Mukherjee, S., … Zanovello, P. (2011). Modulation of microRNA expression in human T‐ cell development: Targeting of NOTCH3 by miR‐150. Blood, 117(26), 7053–7062

Ghorpade DS,Sinha AY,Holla S,Singh V,Balaji KN.NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem.2013;288:33037-33048

Gillett HR,Arnott ID,McIntyre M,Campbell S,Dahele A,Priest M,Jackson R,Ghosh S.Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology.2002;122:800-805

Ginsburg, C. H., Dambrauskas, J. T., Ault, K. A., & Falchuk, Z. M. (1983). Impaired natural killer cell activity in patients with inflammatory bowel disease: Evidence for a qualitative defect. Gastroenterology, 85(4), 846–851

Hanauer, S. B. (2006). Inflammatory bowel disease: Epidemiology,pathogenesis, and therapeutic opportunities.Inflammatory BowelDiseases,12(Suppl. 1), S3–S9

Heidary, M. F., Mahmoodzadeh Hosseini, H., Mehdizadeh Aghdam, E., Nourani, M. R., Ranjbar, R., Mirnejad, R., & Imani Fooladi, A. A. (2015). Overexpression of metastatic related microRNAs, Mir‐335 and Mir‐ 10b, by staphylococcal enterotoxin B in the metastatic breast cancer cell line. Advanced Pharmaceutical Bulletin, 5(2), 255–259. Jun

Heyn, J., Ledderose, C., Hinske, L. C., Limbeck, E., Möhnle, P., Lindner, H. A., & Kreth, S. (2012). Adenosine A2A receptor upregulation in human PMNs is controlled by miRNA‐214, miRNA‐15, and miRNA‐16. Shock, 37(2), 156–163

Ho, S., Pothoulakis, C., & Koon, H. W. (2013). Antimicrobial peptides andcolitis. Current Pharmaceutical Design,19(1), 40–47

Hong Y,Wu J,Zhao J,Wang H,Liu Y,Chen T,Kan X,Tao Q,Shen X,Yan K.miR-29b and miR-29c are involved in Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid dendritic cells. PLoS One.2013;8:e69926

Hu R, Kagele DA, Huffaker TB, Runtsch MC, Alexander M, Liu J, Bake E, Su W, Williams MA, Rao DS, Möller T, Garden GA, Round JL, O’Connell RM. miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity 2014; 41: 605-619 [PMID: 25367574 DOI: 10.1016/ j.immuni.2014.09.015]

Jones, H. R., Robb, C. T., Perretti, M., & Rossi, A. G. (2016). The role of neutrophils in inflammation resolution, Seminars in immunology. Elsevier

Kalla R, Ventham NT, Kennedy NA, et al. Gut 2014;0:1–14. doi:10.1136/gutjnl-2014-307891

Karrich JJ,Jachimowski LC,Libouban M,Iyer A,Brandwijk K,Taanman-Kueter EW,Nagasawa M,de Jong EC,Uittenbogaart CH,Blom B.MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood.2013;122:3001-3009.

Kaser, A., Zeissig, S., & Blumberg, R. S. (2009). Inflammatory boweldisease.Annual Review of Immunology,28, 573–621.

Kracht M,Saklatvala J.Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine.2002;20:91-106.

Larmonier, C. B., Shehab, K. W., Ghishan, F. K., & Kiela, P. R. (2015). T lymphocyte dynamics in inflammatory bowel diseases: Role of the microbiome. BioMed Research International, 2015, 2015–2019

Li, D., Wang, X., Lan, X., Li, Y., Liu, L., Yi, J., … Lu, S. (2015). Down‐regulation of miR‐144 elicits proinflammatory cytokine production by targeting toll‐like receptor 2 in nonalcoholic steatohepatitis of high‐fat‐diet‐ induced metabolic syndrome E3 rats. Molecular and Cellular Endocrinology, 402, 1–12

Li, G., Yu, M., Lee, W.‐W., Tsang, M., Krishnan, E., Weyand, C. M., & Goronzy, J. J. (2012). Decline in miR‐181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nature Medicine, 18(10), 1518–1524.

Li, J., Gong, J., Li, P., Li, M., Liu, Y., Liang, S., & Gong, J. (2014). Knockdown of microRNA‐155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts. Transplantation, 97(6), 626–635.

Lin HS,Gong JN,Su R,Chen MT,Song L, Shen C,Wang F,Ma YN,Zhao HL,Yu J.miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression. J Leukoc Biol.2014;96:1023-1035.

Liu X,Zhan Z,Xu L,Ma F,Li D,Guo Z,Li N,Cao X.MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. J Immunol.2010;185:7244-7251.

Liu, L. Y., Schaub, M. A., Sirota, M., & Butte, A. J. (2011). Transmission distortion in Crohn’s disease risk gene ATG16L1 leads to sex difference in disease association. Inflammatory Bowel Diseases, 18(2), 312–322.

Lu C,Huang X,Zhang X,Roensch K,Cao Q,Nakayama KI,Blazar BR,Zeng Y,Zhou X.miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood.2011;117:4293-4303.

Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, Loeb GB, Lee H, Yoshimura A, Rajewsky K, Rudensky AY. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009; 30: 80-91 [PMID: 19144316 DOI: 10.1016/j.immuni.2008.11.010]

Lu, Z.‐J., Wu, J.‐J., Jiang, W.‐L., Xiao, J.‐H., Tao, K.‐Z., Ma, L., … Wang, X.‐P. (2017). MicroRNA‐155 promotes the pathogenesis of experimental colitis by repressing SHIP‐1 expression. World Journal of Gastroenterology, 23(6), 976.

Ma, F., Xu, S., Liu, X., Zhang, Q., Xu, X., Liu, M., … Cao, X. (2011). The microRNA miR‐29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon‐γ. Nature Immunology, 12(9), 861–869

Matsumoto A., Nakayama K.I., Hidden Peptides Encoded by Putative Noncoding RNAs. Cell Structure and Function. 2018; 43 (1) : 75-83

McKenna LB,Schug J,Vourekas A,McKenna JB,Bramswig NC,Friedman JR,Kaestner KH.MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology.2010;139:1654-1664, 1664.e1.

Mi QS,Xu YP,Wang H,Qi RQ,Dong Z,Zhou L.Deletion of microRNA miR-223 increases Langerhans cell cross-presentation. Int J Biochem Cell Biol.2013;45:395-400

Min, S., Li, L., Zhang, M., Zhang, Y., Liang, X., Xie, Y., Yang, R. (2012). TGF‐β‐associated miR‐27a inhibits dendritic cell‐mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7. Genes and Immunity, 13(8), 621–631.

Moein S, Vaghari‐Tabari M, Qujeq D,Majidinia M, Nabavi SM, Yousefi B. MiRNAs and inflammatorybowel disease: An interesting new story.J Cell Physiol.2018;1–17

Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202: 261-269 [PMID: 16009718 DOI: 10.1084/ jem.20050678]

Naghdalipour M., Moradi N., Fadaei R., Barez S.R., Sayyahfar S., Mokhtare M.,et al. (2020): Alteration of miR-21, miR-433 and miR-590 tissue expression related to the TGF-β signaling pathway in ulcerative colitis patients, Archives of Physiology and Biochemistry, DOI: 10.1080/13813455.2020.1762656

Nahid MA,Satoh M,Chan EK.MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol.2011;8:388-403.

Neurath, M. F. (2014). Cytokines in inflammatory bowel disease. Nature Reviews Immunology, 14(5), 329–342.

O’Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33: 607-619 [PMID: 20888269 DOI: 10.1016/j.immuni.2010.09.009]

O’Connell RM,Taganov KD,Boldin MP,Cheng G,Baltimore D.MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA.2007;104:1604-1609.

Park H,Huang X,Lu C,Cairo MS,Zhou X.MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem.2015;290:2831-2841.

Pastorelli, L., De Salvo, C., Mercado, J. R., Vecchi, M., & Pizarro, T. T.(2013). Central role of the gut epithelial barrier in the pathogenesis ofchronic intestinal inflammation: Lessons learned from animal models and human genetics. Frontiers in immunology,4, 280

Podolsky, D. K. (1991). Inflammatory bowel disease.New England Journal of Medicine,325(13), 928–937

Rodriguez A,Vigorito E,Clare S,Warren MV,Couttet P,Soond DR,van Dongen S,Grocock RJ,Das PP,Miska EA.Requirement of bic/microRNA-155 for normal immune function. Science.2007;316:608-611.

Roy, S. (2016). MiRNA in macrophage development and function. Antioxidants & Redox Signaling, 25(15), 795–804.

Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008). Regulatory T cells and immune tolerance. Cell, 133(5), 775–787.

Shen L,Su L,Turner JR.Mechanisms and functional implications of intestinal barrier defects. Dig Dis.2009;27:443-449.

Shen, Y., Zhou, M., Yan, J., Gong, Z., Xiao, Y., Zhang, C., … Chen, Y. (2016). MiR‐200b inhibits TNF‐α‐induced IL‐8 secretion and tight junction disruption of intestinal epithelial cells in vitro. American Journal of Physiology‐Gastrointestinal and Liver Physiology, 312(2), G123–G132

Singh, U. P., Murphy, A. E., Enos, R. T., Shamran, H. A., Singh, N. P., Guan, H., … Nagarkatti, P. S. (2014). MiR‐155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology, 143(3), 478–489

Smigielska‐Czepiel, K., van den Berg, A., Jellema, P., Slezak‐Prochazka, I., Maat, H., van den Bos, H., Kroesen, B. J. (2013). Dual role of miR‐21 in CD4+ T‐cells: Activation‐induced miR‐21 supports survival of memory T‐cells and regulates CCR7 expression in naive T‐cells. PLoS One, 8(10), e76217

Smyth LA,Boardman DA,Tung SL,Lechler R,Lombardi G.MicroRNAs affect dendritic cell function and phenotype. Immunology.2015;144:197-205.

Soroosh A. , Koutsioumpa M., Pothoulakis C., Iliopoulos D. Functional role and therapeutic targeting of microRNAs in Inflammatory Bowel Disease. Am J Physiol Gastrointest Liver Physiol (November 16, 2017). doi:10.1152/ajpgi.00268.2017

Steiner, D. F., Thomas, M. F., Hu, J. K., Yang, Z., Babiarz, J. E., Allen, C. D. C., … Ansel, K. M. (2011). MicroRNA‐29 regulates T‐box transcription factors and interferon‐γ production in helper T cells. Immunity, 35(2), 169–181

Strober, W., Asano, N., Fuss, I., Kitani, A., & Watanabe, T. (2014). Cellularand molecular mechanisms underlying NOD2 risk‐associated poly-morphisms in Crohn’s disease.Immunological Reviews,260(1),249–260

Sullivan, R. P., Fogel, L. A., Leong, J. W., Schneider, S. E., Wong, R., Romee, R., … Fehniger, T. A. (2013). MicroRNA‐155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways. The Journal of Immunology, 191(12), 5904–5913

Talebi, F., Ghorbani, S., Chan, W. F., Boghozian, R., Masoumi, F., Ghasemi, S., … Noorbakhsh, F. (2017). MicroRNA‐142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. Journal of Neuroinflammation, 14(1), 55.

Tang, Y., Zhang, L., Forsyth, C. B., Shaikh, M., Song, S., & Keshavarzian, A. (2015). The role of miR‐212 and iNOS in alcohol‐induced intestinal barrier dysfunction and steatohepatitis. Alcoholism: Clinical and Experimental Research, 39(9), 1632–1641.

Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604-608 [PMID: 17463289 DOI: 10.1126/science.1141229]

Тhukral C,Cheifetz A,Peppercorn MA.Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date. Drugs.2006;66:2059-2065

Tian R,Wang RL,Xie H,Jin W,Yu KL.Overexpressed miRNA-155 dysregulates intestinal epithelial apical junctional complex in severe acute pancreatitis. World J Gastroenterol.2013;19:8282-8291.

Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol.2009;9:799-809.

Vermeire, S., Van Assche, G., & Rutgeerts, P. (2004). C‐reactive protein asa marker for inflammatory bowel disease.Inflammatory Bowel Diseases,10(5), 661–665.

Wang and Chen. microRNAs as therapeutic targets in intestinal diseases. ExRNA (2019) 1:23

Wang, L., Zhang, R., Chen, J., Wu, Q., & Kuang, Z. (2017). Baicalin protects against TNF‐α‐induced injury by down‐regulating miR‐191a that targets the tight junction protein ZO‐1 in IEC‐6 cells. Biological and Pharmaceutical Bulletin, 40(4), 435–443.

Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009;136:26–36.

Xu XM, Zhang HJ.miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.World J Gastroenterol 2016;22(7): 2206-2218

Ye D,Guo S,Al-Sadi R,Ma TY.MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology.2011;141:1323-1333.

Zhang L, Cheng J, Fan XM.MicroRNAs: New therapeutic targets for intestinal barrier dysfunction.World J Gastroenterol2014;20(19): 5818-5825

Zhang M, Liu F,Jia H,Zhang Q,Yin L,Liu W,Li H,Yu B,Wu J.Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1. J Immunol.2011;187:1674-1683.

Zhang N, Bevan MJ. Dicer controls CD8+ T-cell activation, migration, and survival. Proc Natl Acad Sci USA 2010; 107: 21629-21634 [PMID: 21098294 DOI: 10.1073/pnas.1016299107]

Zhang, C., Xi, X., Wang, Q., Jiao, J., Zhang, L., Zhao, H., & Lai, Z. (2015). The association between serum miR‐155 and natural killer cells from tuberculosis patients. International Journal of Clinical and Experimental Medicine, 8(6), 9168–9172.

Zhang, C., Zhao, Z., Osman, H., Watson, R., Nalbantoglu, I., & Lin, J. (2014). Differential expression of miR‐31 between inflammatory bowel disease and microscopic colitis. Microrna, 3(3), 155–159.

Zhang, J., Cheng, Y., Cui, W., Li, M., Li, B., & Guo, L. (2014). MicroRNA‐155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 266(1), 56–63.

Zhang, L., Shen, J., Cheng, J., & Fan, X. (2015). MicroRNA‐21 regulates intestinal epithelial tight junction permeability. Cell Biochemistry and Function, 33(4), 235–240.

Zhou B, Wang S,Mayr C,Bartel DP,Lodish HF.miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA.2007;104:7080-708

Zhou, L., Chong, M. M. W., & Littman, D. R. (2009). Plasticity of CD4+ T cell lineage differentiation. Immunity, 30(5), 646–655.

Zhu, J., & Paul, W. E. (2008). CD4 T cells: Fates, functions, and faults. Blood, 112(5), 1557–1569

Zou, T., Jaladanki, S. K., Liu, L., Xiao, L., Chung, H. K., Wang, J.‐Y., … Wang, J.‐Y. (2016). H19 long noncoding RNA regulates intestinal epithelial barrier function via microRNA 675 by interacting with RNA‐binding protein HuR. Molecular and Cellular Biology, 36(9), 1332–1341.



Font Size